Search Results - "Santer, P"

Potential for using simulated altitude as a means of prehabilitation: a physiology study by Brown, L A, Griffiths, J A, Santer, P, Jakeman, P M, Smith, T G

“…The current pandemic of surgical complications necessitates urgent and pragmatic innovation to reduce postoperative morbidity and mortality, which are…”
Get full text

A comparison of postoperative respiratory complications associated with the use of desflurane and sevoflurane: a single‐centre cohort study by Zucco, L., Santer, P., Levy, N., Hammer, M., Grabitz, S. D., Nabel, S., Ramachandran, S. K.

“…Summary Sevoflurane and desflurane are the most commonly used volatile anaesthetics for maintenance of anaesthesia. In this study, we aimed to evaluate the…”
Get full text

The development and validation of the Score for the Prediction of Postoperative Respiratory Complications (SPORC‐2) to predict the requirement for early postoperative tracheal re‐intubation: a hospital registry study by Lukannek, C., Shaefi, S., Platzbecker, K., Raub, D., Santer, P., Nabel, S., Lecamwasam, H.S., Houle, T.T., Eikermann, M.

“…Summary Postoperative pulmonary complications are associated with an increase in mortality, morbidity and healthcare utilisation. The Agency for Healthcare…”
Get full text

Circulating microRNA-122 is associated with incident metabolic syndrome and type-2 diabetes by Willeit, P, Yin, X, Kaudewitz, D, Skroblin, P, Zampetaki, A, Moschen, A.R, Ramirez, C.M, Goedeke, L, Rotllan, N, Bonora, E, Hughes, A.D, Santer, P, Fernandez-Hernando, C, Tilg, H, Willeit, J, Kiechl, S, Mayr, M

Get full text

Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease by KIECHL, S, MUIGG, A, WILLEIT, J, SANTER, P, MITTERER, M, EGGER, G, OBERHOLLENZER, M, OBERHOLLENZER, F, MAYR, A, GASPERI, A, POEWE, W

“…The potential role of activated protein C (APC) resistance in arterial thrombosis and disease is a matter of ongoing controversy. In the present…”
Get full text

Major Lipids, Apolipoproteins, and Risk of Vascular Disease by Di Angelantonio, Emanuele, Sarwar, Nadeem, Perry, Philip, Kaptoge, Stephen, Ray, Kausik K, Thompson, Alexander, Wood, Angela M, Lewington, Sarah, Sattar, Naveed, Packard, Chris J, Collins, Rory, Thompson, Simon G, Danesh, John

“…CONTEXT Associations of major lipids and apolipoproteins with the risk of vascular disease have not been reliably quantified. OBJECTIVE To assess major lipids…”
Get full text

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies by Sarwar, Nadeem, Sandhu, Manjinder S, Ricketts, Sally L, Butterworth, Adam S, Di Angelantonio, Emanuele, Boekholdt, S Matthijs, Ouwehand, Willem, Watkins, Hugh, Samani, Nilesh J, Saleheen, Danish, Lawlor, Debbie, Reilly, Muredach P, Hingorani, Aroon D, Talmud, Philippa J, Danesh, John

“…Summary Background Whether triglyceride-mediated pathways are causally relevant to coronary heart disease is uncertain. We studied a genetic variant that…”
Get full text

Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease by KIECHL, Stefan, SCHETT, Georg, WENNING, Gregor, REDLICH, Kurt, OBERHOLLENZER, Martin, MAYR, Agnes, SANTER, Peter, SMOLEN, Josef, POEWE, Werner, WILLEIT, Johann

“…Osteoprotegerin is a novel member of the tumor necrosis factor receptor superfamily and a soluble decoy receptor of the receptor activator of nuclear…”
Get full text

Using static and dynamic canonical correlation coefficients as quantitative EEG markers for Alzheimer's disease severity by Waser, M., Garn, H., Deistler, M., Benke, T., Dal-Bianco, P., Ransmayr, G., Schmidt, H., Sanin, G., Santer, P., Caravias, G., Seiler, S., Grossegger, D., Fruehwirt, W., Schmidt, R.

“…We analyzed the relation between Alzheimer's disease (AD) severity as measured by Mini-Mental State Examination (MMSE) scores and quantitative…”
Get full text

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases by Danesh, J, Erqou, S, Walker, M, Thompson, S G, Tipping, R, Ford, C, Pressel, S, Walldius, G, Jungner, I, Folsom, A R, Chambless, L E, Knuiman, M, Whincup, P H, Wannamethee, S G, Morris, R W, Willeit, J, Kiechl, S, Santer, P, Mayr, A, Wald, N, Ebrahim, S, Lawlor, D A, Yarnell, J W G, Gallacher, J, Casiglia, E, Tikhonoff, V, Nietert, P J, Sutherland, S E, Bachman, D L, Keil, J E, Cushman, M, Psaty, B M, Tracy, R P, Tybjaerg-Hansen, A, Nordestgaard, B G, Frikke-Schmidt, R, Giampaoli, S, Palmieri, L, Panico, S, Vanuzzo, D, Pilotto, L, Simons, L, McCallum, J, Friedlander, Y, Fowkes, F G R, Lee, A J, Smith, F B, Taylor, J, Guralnik, J, Phillips, C, Wallace, R, Blazer, D, Khaw, K T, Jansson, J H, Donfrancesco, C, Salomaa, V, Harald, K, Jousilahti, P, Vartiainen, E, Woodward, M, D'Agostino, R B, Wolf, P A, Vasan, R S, Pencina, M J, Bladbjerg, E M, Jorgensen, T, Moller, L, Jespersen, J, Dankner, R, Chetrit, A, Lubin, F, Rosengren, A, Wilhelmsen, L, Lappas, G, Eriksson, H, Bjorkelund, C, Cremer, P, Nagel, D, Tilvis, R, Strandberg, T, Rodriguez, B, Bouter, L M, Heine, R J, Dekker, J M, Nijpels, G, Stehouwer, C D A, Rimm, E, Pai, J, Sato, S, Iso, H, Kitamura, A, Noda, H, Goldbourt, U, Salonen, J T, Nyyssönen, K, Tuomainen, T-P, Deeg, D, Poppelaars, J L, Meade, T

“…Many long-term prospective studies have reported on associations of cardiovascular diseases with circulating lipid markers and/or inflammatory markers. Studies…”
Get full text

Inhibition of profibrotic microRNA-21 affects platelets and their releasate by Barwari, Temo, Eminaga, Seda, Mayr, Ursula, Lu, Ruifang, Armstrong, Paul C, Chan, Melissa V, Sahraei, Mahnaz, Fernández-Fuertes, Marta, Moreau, Thomas, Barallobre-Barreiro, Javier, Lynch, Marc, Yin, Xiaoke, Schulte, Christian, Baig, Ferheen, Pechlaner, Raimund, Langley, Sarah R, Zampetaki, Anna, Santer, Peter, Weger, Martin, Plasenzotti, Roberto, Schosserer, Markus, Grillari, Johannes, Kiechl, Stefan, Willeit, Johann, Shah, Ajay M, Ghevaert, Cedric, Warner, Timothy D, Fernández-Hernando, Carlos, Suárez, Yajaira, Mayr, Manuel

“…Fibrosis is a major contributor to organ disease for which no specific therapy is available. MicroRNA-21 (miR-21) has been implicated in the fibrogenetic…”
Get full text

Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis : Prospective results from the Bruneck study by KRONENBERG, F, KRONENBERG, M. F, KIECHL, S, TRENKWALDER, E, SANTER, P, OBERHOLLENZER, F, EGGER, G, UTERMANN, G, WILLEIT, J

“…Experimental studies have suggested both atherogenic and thrombogenic properties of lipoprotein(a) [Lp(a)], depending on Lp(a) plasma concentrations and…”
Get full text

Marburg I polymorphism of factor VII: Activating protease a prominent risk predictor of carotid stenosis by WILLEIT, Johann, KIECHL, Stefan, WEIMER, Thomas, MAIR, Artur, SANTER, Peter, WIEDERMANN, Christian J, ROEMISCH, Juergen

“…Atherothrombosis is a main pathomechanism in the evolution of vessel stenosis and is counteracted by endogenous fibrinolysis. Recently, the plasmatic serine…”
Get full text

Covariate-adjusted measures of discrimination for survival data by White, Ian R., Rapsomaniki, Eleni

“…Motivation Discrimination statistics describe the ability of a survival model to assign higher risks to individuals who experience earlier events: examples are…”
Get full text

The practical effects of the issues of standardization of erythropoietin automated assay by Dorizzi, R M, Mayr, A, Meneghelli, S, Santer, P

Get full text

Comparison of hematologic data in world elite junior speed skaters and in non-athletic juniors by Mayr, A, Kuipers, H, Falk, M, Santer, P, Wierer, B

“…During the world junior speed skating championship 2002 all athletes (60 males, 56 females) were subjected to hematologic blood testing one day before the…”
Get more information

Lipoprotein(a) and asymptomatic carotid artery disease : evidence of a prominent role in the evolution of advanced carotid plaques : the Bruneck Study by WILLEIT, J, KIECHL, S, SANTER, P, OBERHOLLENZER, F, EGGER, G, JAROSCH, E, MAIR, A

“…Elevated levels of lipoprotein(a) [Lp(a)] have been reported in association with symptomatic coronary and carotid artery disease. Relevancy of Lp(a) as a risk…”
Get full text

Suppressing lactation by Santer, Patricia M

Get full text